Your browser doesn't support javascript.
loading
High prevalence of MEF2D fusion in human B-cell precursor acute lymphoblastic leukemia cell lines.
Akahane, Koshi; Yasuda, Takahiko; Tsuzuki, Shinobu; Hayakawa, Fumihiko; Kiyokawa, Nobutaka; Somazu, Shinpei; Watanabe, Atsushi; Kagami, Keiko; Abe, Masako; Harama, Daisuke; Goi, Kumiko; Kawazu, Masahito; Kojima, Shinya; Imamura, Toshihiko; Goto, Hiroaki; Iwamoto, Shotaro; Minegishi, Masayoshi; Abe, Masafumi; Hojo, Hiroshi; Inaba, Toshiya; Mano, Hiroyuki; Sugita, Kanji; Inukai, Takeshi.
Afiliação
  • Akahane K; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Yasuda T; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Tsuzuki S; Department of Biochemistry, Aichi Medical University, Nagakute, Japan.
  • Hayakawa F; Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kiyokawa N; Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Somazu S; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Watanabe A; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Kagami K; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Abe M; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Harama D; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Goi K; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Kawazu M; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
  • Kojima S; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
  • Imamura T; Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Goto H; Department of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Iwamoto S; Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.
  • Minegishi M; Japanese Red Cross Miyagi Blood Center, Sendai, Japan.
  • Abe M; Professor Emeritus, Fukushima Medical University, Fukushima, Japan.
  • Hojo H; Department of Clinical Medicine Diagnostic Pathology, Aizu Medical Center, Fukushima Medical University, Aizuwakamatsu, Japan.
  • Inaba T; Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Mano H; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
  • Sugita K; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Inukai T; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Hematol Oncol ; 38(4): 614-617, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32515032

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Proteínas de Fusão Oncogênica Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Hematol Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Proteínas de Fusão Oncogênica Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Hematol Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão